Coronary artery disease Posts on Medivizor
Navigation Menu

Coronary artery disease Posts on Medivizor

Evaluating the effectiveness and safety of ivabradine in combination with beta-blockers in patients with stable angina.

Evaluating the effectiveness and safety of ivabradine in combination with beta-blockers in patients with stable angina.

Posted by on Jan 8, 2023 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of ivabradine (Procoralan) in combination with beta-blockers in patients with stable angina. The data showed that the combination of ivabradine plus beta-blocker therapy effectively reduced heart rate, angina symptoms, and the use of short-acting nitrates from the first month of treatment...

Read More

Evaluating the effect of patient-reported physical and mental health status before PCI/CABG on their long-term outcomes

Evaluating the effect of patient-reported physical and mental health status before PCI/CABG on their long-term outcomes

Posted by on Jan 3, 2023 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effect of patient-reported physical and mental health status before revascularization procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) on their long-term outcomes in patients with coronary artery disease (CAD). The data showed that...

Read More

Comparing the effectiveness and safety between biodegradable and durable polymer drug-eluting stents in patients with acute coronary syndrome.

Comparing the effectiveness and safety between biodegradable and durable polymer drug-eluting stents in patients with acute coronary syndrome.

Posted by on Dec 30, 2022 in Coronary artery disease | 0 comments

In a nutshell This study compared the effectiveness and safety between biodegradable polymer (BP) drug-eluting stents (DES) and durable polymer (DP) DESs in patients with acute coronary syndrome (ACS). The data showed that both stent types demonstrated excellent effectiveness and safety after 1 year. The authors suggested that BP-DES may be more...

Read More

Can icosapent ethyl prevent cardiovascular events and mortality in patients that have had previous heart attacks?

Can icosapent ethyl prevent cardiovascular events and mortality in patients that have had previous heart attacks?

Posted by on Dec 9, 2022 in Coronary artery disease | 0 comments

In a nutshell This study examined the effect of icosapent ethyl (IPE; Vascepa) on major cardiovascular events (MACEs) in statin-treated patients that had previous heart attacks (myocardial infarction; MI). The data showed that patients treated with IPE had large and significant reductions in MACEs. Some background Ischemic events are associated with a...

Read More

Comparing the effects of a Mediterranean versus a low-fat diet in the secondary prevention of cardiovascular events in patients with coronary artery disease.

Comparing the effects of a Mediterranean versus a low-fat diet in the secondary prevention of cardiovascular events in patients with coronary artery disease.

Posted by on Nov 22, 2022 in Coronary artery disease | 0 comments

In a nutshell This study compared the effects of a Mediterranean versus a low-fat diet in the secondary prevention of major cardiovascular events (MACE) in patients with established coronary artery disease (CAD). The data showed that in secondary prevention, the Mediterranean diet was more effective in preventing MACEs compared to a low-fat diet in...

Read More

Comparing the effectiveness and safety of an early versus a delayed invasive strategy in patients with non-ST elevation acute coronary syndrome.

Comparing the effectiveness and safety of an early versus a delayed invasive strategy in patients with non-ST elevation acute coronary syndrome.

Posted by on Oct 13, 2022 in Coronary artery disease | 0 comments

In a nutshell This study compared the effectiveness and safety of an early and a delayed invasive strategy (IS) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). The data showed that there were no significant differences in the risk of death, heart attacks, stroke rates, major bleeding, or revascularization between early and delayed...

Read More

Comparing the effectiveness and safety of short-term versus long-term dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk.

Comparing the effectiveness and safety of short-term versus long-term dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk.

Posted by on Oct 7, 2022 in Coronary artery disease | 0 comments

In a nutshell This study compared the effectiveness and safety of short-term versus long-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) using drug-eluting stents (DES) in patients at high bleeding risk. The data showed that short-term DAPT significantly reduced the risk of bleeding compared with long-term DAPT...

Read More

Comparing the effectiveness and safety of percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main coronary artery disease.

Comparing the effectiveness and safety of percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main coronary artery disease.

Posted by on Sep 17, 2022 in Coronary artery disease | 0 comments

In a nutshell This study compared the effectiveness and safety of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) in patients with left main (LM) coronary artery disease (CAD). The data showed that both treatments were associated with a similar risk of heart attack, stroke, and death....

Read More

Evaluating the effect of trimetazidine for the treatment of patients with ischemic heart disease who are not suitable for revascularization.

Evaluating the effect of trimetazidine for the treatment of patients with ischemic heart disease who are not suitable for revascularization.

Posted by on May 31, 2022 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effectiveness of trimetazidine (Vastarel) versus other anti-anginal drugs for the treatment of patients with ischemic heart disease (IHD) who are not suitable for revascularization. The data showed that trimetazidine improved walking time and angina attacks in these patients. Some background Coronary artery...

Read More

Is clopidogrel better than ticagrelor in reducing bleeding in stabilized patients with myocardial infarction undergoing percutaneous coronary intervention ?

Is clopidogrel better than ticagrelor in reducing bleeding in stabilized patients with myocardial infarction undergoing percutaneous coronary intervention ?

Posted by on May 8, 2022 in Coronary artery disease | 0 comments

In a nutshell This study investigated if de-escalation (reducing the intensity) of dual antiplatelet therapy (DAPT) with clopidogrel (Plavix) might be better than ticagrelor (Brilique)-based antiplatelet therapy in stabilized patients with acute myocardial infarction (MI; heart attack) undergoing percutaneous coronary intervention (PCI). The data...

Read More

Is yoga-based cardiac rehabilitation beneficial for patients with coronary artery disease?

Is yoga-based cardiac rehabilitation beneficial for patients with coronary artery disease?

Posted by on Jan 30, 2022 in Coronary artery disease | 0 comments

In a nutshell This study evaluated if yoga-based cardiac rehabilitation leads to reduced heart-related risk factors in patients with coronary artery disease (CAD) compared to standard care. The data showed that the addition of yoga to standard care showed overall improvements in the cardiac health and quality of life of these patients. Some...

Read More